n-methyl-3,4-methylenedioxyamphetamine has been researched along with phenylephrine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Docherty, JR; McDaid, J | 1 |
Badon, LA; Hicks, A; Lord, K; Meleg-Smith, S; Ogden, BA; Varner, KJ | 1 |
2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and phenylephrine
Article | Year |
---|---|
Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Anesthesia; Animals; Blood Pressure; Electric Stimulation; Electrodes; Male; Methiothepin; N-Methyl-3,4-methylenedioxyamphetamine; Pentobarbital; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Serotonin Antagonists; Tachycardia; Xylazine | 2001 |
Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy.
Topics: Acetylcholine; Animals; Atropine; Blood Pressure; Drug Interactions; Electrocardiography; Hallucinogens; Heart Diseases; Heart Rate; Hemodynamics; Injections, Intravenous; Male; Muscarinic Antagonists; Myocardium; N-Methyl-3,4-methylenedioxyamphetamine; Nitroprusside; Phenylephrine; Rats; Rats, Sprague-Dawley; Substance-Related Disorders; Telemetry; Vasoconstrictor Agents; Vasodilator Agents | 2002 |